Microfluidic Nucleic Acid Assay Using Magnetic Bead Transport

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing diagnostic technologies are cumbersome, require complex logistics, and lack the ability to efficiently detect and quantify multiple nucleic acids without enzymatic reagents, making them costly and difficult to use in portable settings.

Innovation Solution

A compact, portable diagnostic device using magnetic beads and PNA probes within a microfluidic system for nucleic acid detection, with stages defined by channels and barriers, allowing for self-contained sample preparation and analysis without enzymatic reagents, and capable of detecting multiple targets with high specificity and sensitivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional diagnostic technologies are used, then detection capability is achieved, but device complexity and logistics requirements increase

Engineering Contradiction:
Improvedetection capabilityVSAvoiddevice complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The diagnostic system is segmented into a portable field device for sample collection and preliminary processing, and a centralized laboratory reader for final analysis. The field device contains only essential components (magnetic beads, PNA probes, microfluidic channels) while complex functions (data processing, result interpretation) are relocated to the laboratory system.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Enzymatic reagents and complex biochemical processing steps are extracted from the portable field device and replaced with non-enzymatic PNA probe-based detection. This removes the need for temperature-controlled storage and complex incubation equipment, significantly simplifying the field device while maintaining detection capability.

Inventive Principle:
Principle #2Taking out (Extraction)

2Measurement precision

If enzymatic reagents are used for nucleic acid detection, then assay sensitivity is improved, but logistics complexity and cost increase

Engineering Contradiction:
Improveassay sensitivityVSAvoidlogistics complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system uses disposable PNA probes that are stable at ambient temperature and do not require enzymatic reactions. These probes can be synthesized chemically without biological materials, eliminating the need for cold chain logistics and complex reagent storage while maintaining sufficient detection sensitivity for diagnostic applications.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The detection methodology transitions from enzymatic amplification (requiring precise temperature control and multiple reagents) to direct hybridization-based detection using PNA probes. This parameter change in the detection mechanism eliminates logistical complexity while preserving the ability to detect and quantify target nucleic acids.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If multiple nucleic acid targets are detected simultaneously, then diagnostic versatility is improved, but device complexity increases

Engineering Contradiction:
Improvedetection versatilityVSAvoiddevice complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The portable device is designed with universal components that can detect multiple nucleic acid targets: a single microfluidic chip architecture, reusable magnetic bead technology, and interchangeable PNA probe sets. By standardizing the detection platform and only changing the probe sequences for different targets, the system achieves multi-target capability without proportionally increasing device complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient, cost-effective, and reproducible detection of multiple nucleic acids in a portable format, minimizing sample preparation steps and reducing the need for maintenance, while maintaining high assay accuracy and sensitivity.

Implementation Method 1

Magnetic particles used for capturing and transporting the analyte (transport or 'T-beads')

Methodology Applied
Scientific EffectMagnetic field: Magnetic Field

Implementation Method 2

Magnetic particles ('T-beads) suspended in the aqueous phase (i.e. they have a hydrophilic surface) experience a force when an external force is applied, e.g. by a permanent magnet

Methodology Applied
Scientific EffectMagnetic force: Lorentz Force

Implementation Method 3

The analyte is captured on the T-bead by a probe (Probe1) that is either pre-attached to the T-bead

Methodology Applied
Scientific EffectProbe binding: Adsorption

Implementation Method 4

Cohesive forces between the water molecules exclude oil molecules (e.g. silicone oil or cycloalkanes) creating an aqueous phase/oil phase interface and barrier to the transition of hydrophilic molecules and hydrophilic particles

Methodology Applied
Scientific EffectInterfacial tension: Surface Tension

Implementation Method 5

capacitive sensors arranged to detect and quantify an analyte in a liquid sample over a sensor surface

Methodology Applied
Scientific EffectCapacitance: Capacitance

Implementation Method 6

The channel walls are preferably thin (such as less than 3 mm) to allow for good thermal conductivity

Methodology Applied
Scientific EffectThermal conduction: Conduction (thermal)

Data Source

PatentUS12553078B2Diagnostic device and system
Publication Date: 2026.02.17 ALTRATECH LTD
  • US12553078B2 patent drawing
  • US12553078B2 patent drawing
  • US12553078B2 patent drawing

AI summary

A portable diagnostic device has a lysate stage (167) with a port for receiving a sample and containing magnetic beads with a probe, and an outlet port. A series of assay stages (161-164) are linked with the lysate vessel, each with a reservoir linked by channels. The final stage (164) has a sensor (169) for detecting beads attached to analyte molecules which have been conveyed according to attachment to probes on beads. Larger transport beads cause reporter beads which are tethered by target NA and probes to be transported to the final sensor stage, where they are released and detected when the transport beads have been removed.